SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950133-98-002701
Filing Date
1998-07-23
Accepted
1998-07-23 00:00:00
Documents
2
Group Members
BB BIOTECH AGBIOTECH FOCUS S.A.
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G RE: BIOCHEM PHARMA, INC. SC 13G 13774
2 JOINT FILING AGREEMENT EX-99.3 1745
  Complete submission text file 0000950133-98-002701.txt   17674
Mailing Address 275 ARMAND FRAPPIER BLVD LAVAL QUEBEC E6
Business Address 275 ARMAND-FRAPPIER BLVD LAVAL QUEBEC E6 5146811744
BIOCHEM PHARMA INC (Subject) CIK: 0000867202 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E6 | Fiscal Year End: 0131
Type: SC 13G | Act: 34 | File No.: 005-45089 | Film No.: 98670435
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006
Business Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006 2028351882
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: DC | Fiscal Year End: 1231
SIC: 0000